|
|
Tweet |
Breast cancer boost
Boston, MA - WOMEN with early breast cancer who are treated with the drug Herceptin have almost a 50 per cent reduced risk of the disease returning, according to research published today.
Now results published in the New England Journal of Medicine have confirmed that Herceptin reduced the risk of disease returning in women with some early-stage cancer by 46 per cent .
